SOP Guide for Pharma

Aerosol: SOP for Releasing Finished Aerosol Products – V 2.0

Aerosol: SOP for Releasing Finished Aerosol Products – V 2.0

SOP for Releasing Finished Aerosol Products

Department Aerosol
SOP No. SOP/Aerosol/090/2025
Supersedes SOP/Aerosol/090/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

This Standard Operating Procedure (SOP) outlines the process for releasing finished aerosol products for distribution. The objective is to ensure that only products that meet established quality standards, including safety, efficacy, and regulatory compliance, are released for sale. The release process ensures that all necessary checks, documentation, and approvals are completed before a product reaches the customer.

2. Scope

This SOP applies to all finished aerosol products manufactured at [Company Name]. It covers the activities required to verify the product’s conformance to specifications, review of batch records, testing results, and final approval before release.

3. Responsibilities

  • Quality Assurance (QA) Team: Responsible for reviewing batch records, ensuring all required testing has been completed, approving the release of finished products, and ensuring compliance with GMP and regulatory requirements.
  • Production Team: Responsible for ensuring that the manufacturing process is completed according to approved procedures and that any deviations or non-conformances are reported to QA for investigation.
  • Quality Control (QC) Team: Responsible for conducting all required testing (e.g., physical, chemical, microbiological) on finished aerosol products and reporting results to the QA team.
  • Regulatory Affairs Team: Ensures that all
released products comply with regulatory requirements and that any necessary notifications or reports are made to regulatory authorities.

4. Accountability

The Manufacturing Manager is accountable for ensuring that finished aerosol products meet all release criteria and comply with this SOP. The overall compliance with this SOP is overseen by the Quality Assurance (QA) Manager.

5. Procedure

5.1. Completion of Manufacturing and Final Inspection

  1. The production team will complete the manufacturing process, including filling, packaging, labeling, and final inspection of the aerosol products. All work must be documented in the batch records.
  2. The production team will perform a final inspection of each batch to ensure that the aerosol cans are properly sealed, labeled, and meet packaging specifications.
  3. If the batch is found to have any defects during the final inspection (e.g., labeling errors, leaks, or underfills), the batch will be segregated and flagged for investigation. The deviation should be documented in the Deviation Log (Annexure-1).

5.2. Review of Batch Records

  1. The QA team will review the batch records, which should include:
    • Raw material usage logs
    • Production and packaging parameters
    • Test results (e.g., fill weights, valve testing, leak testing)
    • Operator and supervisor signatures
    • Cleaning and maintenance records for the equipment used
  2. QA will ensure that all required testing has been completed and that the results are within the specified limits.
  3. If any discrepancies or missing information are found during the review, the batch will not be approved for release until corrective actions have been taken. The issue should be documented in the Non-Conformance Log (Annexure-2).

5.3. Quality Control Testing

  1. QC will conduct final testing on the finished aerosol products, including:
    • Fill weights and volume checks
    • Valve performance testing
    • Pressure testing
    • Microbial testing (if applicable)
  2. All QC test results must be documented in the QC Testing Log (Annexure-3) and reviewed by the QA team for compliance with product specifications.
  3. If the QC results do not meet specifications, the batch will not be released, and corrective actions must be taken. The corrective actions and their outcomes should be documented in the Corrective Action Log (Annexure-4).

5.4. Approval for Release

  1. Once all batch records and QC testing results are reviewed and found to be compliant, the QA team will approve the batch for release. The approval will be documented in the Release Approval Log (Annexure-5).
  2. All relevant documents, including batch records, QC test results, and approval forms, should be stored in the document management system for easy retrieval and regulatory inspection.
  3. If the batch does not meet the required standards or if any deviations are unresolved, the batch will not be approved for release, and the corrective actions will be taken as needed.

5.5. Documentation and Record-Keeping

  1. The QA team will ensure that all records related to the batch release process, including batch records, QC test results, deviations, and corrective actions, are properly documented and stored for future reference and audits.
  2. Records must be retained for a minimum of 3 years or as required by regulatory guidelines.

5.6. Reporting and Notification to Regulatory Authorities

  1. If any regulatory issues are identified during the review or testing process, the Regulatory Affairs Team must be notified immediately. The Regulatory Affairs Team will determine if a report or notification to regulatory authorities is necessary.
  2. For batches with significant issues, the QA team must document the problem, corrective actions, and any communications with regulatory authorities in the Incident Report Log (Annexure-6).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • PPE: Personal Protective Equipment
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance

7. Documents

  1. Deviation Log (Annexure-1)
  2. Non-Conformance Log (Annexure-2)
  3. QC Testing Log (Annexure-3)
  4. Corrective Action Log (Annexure-4)
  5. Release Approval Log (Annexure-5)
  6. Incident Report Log (Annexure-6)

8. References

This SOP is based on the following regulatory guidelines and industry standards:

  • Good Manufacturing Practice (GMP) Guidelines
  • FDA Code of Federal Regulations (CFR) Title 21, Part 211
  • ISO 9001:2015 – Quality Management Systems

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Log

Deviation ID Deviation Description Corrective Action Operator Name Approval
DEV-12345 Underfill detected Adjusted filling machine settings Rajesh Patel Approved

Annexure-2: Non-Conformance Log

Non-Conformance ID Non-Conformance Description Corrective Action Responsible Person Status
NC-001 Improper temperature during filling Re-calibrated temperature control Rajesh Patel Completed

Annexure-3: QC Testing Log

Batch Number Test Type Test Result Passed/Failed
Batch-001 Fill weight 500 g Pass

Annexure-4: Corrective Action Log

Deviation ID Corrective Action Implementation Date Responsible Person Status
DEV-12345 Re-calibrated filling machine 07/02/2025 Rajesh Patel Completed

Annexure-5: Release Approval Log

Batch Number Approval Date Approving Authority Comments
Batch-001 10/02/2025 Anjali Sharma Approved for release

Annexure-6: Incident Report Log

Incident ID Incident Description Action Taken Outcome
INC-001 Labeling error detected Re-labeled affected products Resolved, no further issues

12. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By Page No. Ref. Point No. Details of Revision
01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma Page 1 [Ref Point] First Release
01/01/2025 V 2.0 Updated release procedures To comply with updated GMP regulations Anjali Sharma Page 1 [Ref Point] Updated procedures
Exit mobile version